OPPM
GTHX

Opus Point Partners Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Opus Point Partners Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$475K Hold
20,844
– – 0.86% 29
2019
Q2 		$639K Hold
20,844
– – 0.95% 27
2019
Q1 		$346K Buy
+20,844
New +$395K 0.47% 52

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Opus Point Partners Management's GTHX Position: Q3 2019 in Review

Opus Point Partners Management held its G1 Therapeutics, Inc. Common Stock (GTHX) position steady in Q3 2019 at 20,844 shares worth $475K. The position accounts for 0.86% of the portfolio, ranked #29.

Opus Point Partners Management first reported a position in GTHX in Q1 2019 and has held it in 3 quarters since. The position peaked at $639K in Q2 2019. 99 funds tracked by Wall St. Rank hold GTHX as of Q3 2019.

  • Opus Point Partners Management held 20,844 shares of G1 Therapeutics, Inc. Common Stock worth $475K as of Q3 2019.
  • Opus Point Partners Management left its G1 Therapeutics, Inc. Common Stock share count unchanged in Q3 2019.
  • G1 Therapeutics, Inc. Common Stock made up 0.86% of Opus Point Partners Management's portfolio in Q3 2019, its #29 holding.
  • Opus Point Partners Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2019 and has held it in 3 quarters since.
  • Opus Point Partners Management's G1 Therapeutics, Inc. Common Stock position peaked at $639K in Q2 2019.
  • 99 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.